Montelukast Prescribing at STANMORE MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
4,530
Total Quantity
127.7K
NHS Cost
£6.4K
vs National Avg
+561.6%
STANMORE MEDICAL GROUP prescribed 4,530 items of Montelukast over the last 12 months at a cost of £6,426 to the NHS. This is 561.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
409
Jun 2026
389
Jun 2026
437
Jun 2026
383
Jun 2026
334
Jun 2026
407
Jun 2026
390
Jun 2026
366
Jun 2026
368
Jun 2026
361
Jun 2026
345
Jun 2026
341
Prescribing Details
| Total Items | 4,530 |
|---|---|
| Total Quantity | 127,693 |
| Total NHS Cost | £6,426 |
| Presentations | 4 different forms |
| vs National Average | +561.6% |
Montelukast Prescribing Comparison
| This practice | 4,530 items |
|---|---|
| National average per practice | 685 items |
| Difference | +561.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.